NCT00659334 2022-12-21
Imaging of Intravenous (IV) Combidex to Brain, Intra-cerebral Tumors and in Central Nervous System (CNS) Inflammation
OHSU Knight Cancer Institute
Phase 2 Terminated
Clinical Trials
8 trialsNCT00188695 2022-10-07
Combidex USPIO - Ultra-small Superparamagnetic Iron Oxide
University Health Network, Toronto
Phase 1/2 Completed
NCT02253602 2019-01-16
IMPROVE
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Completed
NCT02751606 2018-12-06
Nano MRI on 7 Tesla in Rectal and Breast Cancer
Radboud University Medical Center
Phase 3 Unknown
NCT00920023 2017-07-25
Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)
Massachusetts General Hospital
Phase 4 Completed
NCT00147238 2012-08-07
A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast
M.D. Anderson Cancer Center
Phase NA Terminated
NCT00622973 2011-10-12
USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases
Insel Gruppe AG, University Hospital Bern
Phase 3 Completed
NCT00107484 2010-05-03
Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer
Virginia Commonwealth University
Phase 2 Completed